AMP-activated protein kinase activators (Viteava)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAMP-activated protein kinase activators (Viteava)
Drug Alias NameAMP-activated protein kinase activators (Wayne State University)VEA-005VEA-006
ClassificationSmall molecules
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWayne State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViteava Pharmaceuticals IncWayne State University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A